Proactis (XPAR:PROAC) Research & Development: €0.00 Mil (TTM As of Jul. 2025)


What is Proactis Research & Development?

Proactis XPAR:PROAC Research & Development is €0.00 Mil as of Jul. 2025. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Proactis's Research & Development for the six months ended in Jul. 2025 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jul. 2025 was €0.00 Mil.

Proactis  (XPAR:PROAC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Proactis Research & Development Related Terms

Proactis Research & Development Historical Data

* Premium members only.

The historical data trend for Proactis's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Proactis Research & Development Chart

Proactis Annual Data
Trend Dec14 Dec15 Dec16 Jul18 Jul19 Jul20 Jul21 Jul22 Jan24 Jan25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Proactis Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul24 Jan25 Jul25 Jan26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Proactis Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jul. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
Proactis (XPAR:PROAC) has a Research & Development of €0.00 Mil as of Jul. 2025. Research and development expense is the total cost for research and development activities. View historical data on Proactis and its competitors.
Is Proactis' Research & Development too high?
Proactis' current Research & Development is €0.00 Mil.
How does Proactis' Research & Development compare to CRM and SHOP?
Proactis' Research & Development of €0.00 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Software company?
A good Research & Development depends on the Software industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Proactis and its competitors. Proactis's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proactis stock overvalued right now?
Proactis (XPAR:PROAC) has a current Research & Development of €0.00 Mil. The current Research & Development is €0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Proactis (XPAR:PROAC), the current Research & Development is €0.00 Mil as of Jul. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Proactis Business Description

Address 54 rue de Londres, Paris, FRA, 75008
Proactis SA is involved in providing business software solutions to various organisations. It offers its solutions to Public Sector, Education, Retail, Financial Services, Not-for-Profit, Housing Authorities and Property and Facilities Management among others.